Story perspectives
DataJoint Raises $4.9M to Expand Life Sciences Platform
10/6/2025
1 of 1
Story summary
- DataJoint secured $4.9 million in Seed funding, co-led by Nina Capital, Inoca Capital, and Capital Factory.
- The funds will expand its SaaS platform and team, targeting life sciences and pharmaceutical markets in the U.S. and Europe.
- Platform supports over 100 labs, including Johns Hopkins and Harvard.
- Founded by CTO Dimitri Yatsenko, DataJoint aims to bridge engineering and life sciences.
